Drugs |
Dosage |
Indication |
Mechanism of action |
Modafinil |
100 - 400 mg |
First-line treatment for EDS |
Promotes wakefulness by stimulating histamine (HA), norepinephrine (NE), serotonin (5-HT), dopamine (DA), and orexin systems in the brain [12]. |
Solriamfetol |
75 - 150 mg |
First-line treatment for EDS |
Possible increased activity as a dopamine and norepinephrine reuptake inhibitor [13]. |
Pitolisant |
4.5 - 36.0 mg |
First-line treatment for EDS and cataplexy |
H3 receptor antagonist/inverse agonist [2]. |
Methylphenidate |
10 - 60 mg |
Second-line treatment for EDS |
Non-competitively blocks the reuptake of dopamine and noradrenaline into the terminal by blocking dopamine transporter (DAT) and noradrenaline transporter (NAT), increasing levels of dopamine and noradrenaline in the synaptic cleft [14]. |
Amphetamines |
Amphetamine mixed salts: 10 - 60 mg; Dexamphetamine: 10 - 60 mg |
Second-line treatment for EDS |
Elevates extracellular dopamine (DA) and prolonging DA receptor signaling in the striatum [15]. |